Literature DB >> 519033

[A contribution to the cytostatic long-term chemotherapy of polycythemia vera (author's transl)].

W Fereberger, F P Robier, S Sailer.   

Abstract

From 1967 to 1978 38 patients with polycythemia vera received a long term cytostatic chemotherapy. The results of 14 patients who were given Procarbacin (Natulan) during a mean treatment time of 9 1/2 years are communicated. Two patients showed secondary tumors after 9 or 11 years respectively. The advantages and disadvantages of the various therapeutic approaches in the management of polycythemia in the literature are discussed together with our own experiences.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 519033     DOI： 10.1007/bf01008660

Source DB:  PubMed          Journal:  Blut        ISSN： 0006-5242


  11 in total

1.  POLYCYTHAEMIA VERA: CLINICAL STUDIES ON A SERIES OF 127 PATIENTS MANAGED WITHOUT RADIATION THERAPY.

Authors:  J PERKINS; M C ISRAUELS; J F WILKINSON
Journal:  Q J Med       Date:  1964-10

2.  Complications and causes of death in polycythaemia vera.

Authors:  E CHIEVITZ; T THIEDE
Journal:  Acta Med Scand       Date:  1962-11

3.  The treatment of polycythemia vera.

Authors:  L R Wasserman
Journal:  Semin Hematol       Date:  1976-01       Impact factor: 3.851

4.  Present status of 32P-therapy in management of polycythemia vera.

Authors:  G Meuret
Journal:  Klin Wochenschr       Date:  1975-06-15

5.  A study of hematological complications occurring in patients with polycythemia vera treated with 32-P (based on a series of 296 patients).

Authors:  M Tubiana; R Flamant; E Attie; M Hayat
Journal:  Blood       Date:  1968-10       Impact factor: 22.113

6.  An epidemiological study of polycythemia vera.

Authors:  B Modan
Journal:  Blood       Date:  1965-11       Impact factor: 22.113

Review 7.  [Side-effects of cytostatic therapy with special reference to potential carcinogenic effects].

Authors:  D Schmähl
Journal:  Internist (Berl)       Date:  1971       Impact factor: 0.743

8.  Treatment of polycythaemia vera.

Authors:  P J Watkins; G H Fairley; R B Scott
Journal:  Br Med J       Date:  1967-06-10

9.  Polycythemia vera: stem-cell and probable clonal origin of the disease.

Authors:  J W Adamson; P J Fialkow; S Murphy; J F Prchal; L Steinmann
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

10.  [Polycythemia vera, clinical aspects and disease course].

Authors:  E Heilmann; T Köhler
Journal:  Fortschr Med       Date:  1978-05-11
View more
  1 in total

1.  Myelosuppression in polycythemia vera: chemotherapy or radiotherapy?

Authors:  Y Najean; C Dresch
Journal:  Blut       Date:  1982-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.